151 related articles for article (PubMed ID: 26413856)
1. Contribution of Raman spectroscopy in nephrology: a candidate technique to detect hydroxyethyl starch of third generation in osmotic renal lesions.
Vuiblet V; Nguyen TT; Wynckel A; Fere M; Van-Gulick L; Untereiner V; Birembaut P; Rieu P; Piot O
Analyst; 2015 Nov; 140(21):7382-90. PubMed ID: 26413856
[TBL] [Abstract][Full Text] [Related]
2. Raman-based detection of hydroxyethyl starch in kidney allograft biopsies as a potential marker of allograft quality in kidney transplant recipients.
Vuiblet V; Fere M; Bankole E; Wynckel A; Gobinet C; Birembaut P; Piot O; Rieu P
Sci Rep; 2016 Sep; 6():33045. PubMed ID: 27608775
[TBL] [Abstract][Full Text] [Related]
3. [Volume replacement with hydroxyethyl starch: is there an influence on kidney function?].
Suttner S; Boldt J
Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Feb; 39(2):71-7. PubMed ID: 14767795
[TBL] [Abstract][Full Text] [Related]
4. Association of high volumes of hydroxyethyl starch with acute kidney injury in elderly trauma patients.
Leberle R; Ernstberger A; Loibl M; Merkl J; Bunz M; Creutzenberg M; Trabold B
Injury; 2015 Jan; 46(1):105-9. PubMed ID: 25240412
[TBL] [Abstract][Full Text] [Related]
5. Renal effects of saline-based 10% pentastarch versus 6% tetrastarch infusion in ovine endotoxemic shock.
Ertmer C; Köhler G; Rehberg S; Morelli A; Lange M; Ellger B; Pinto BB; Rübig E; Erren M; Fischer LG; Van Aken H; Westphal M
Anesthesiology; 2010 Apr; 112(4):936-47. PubMed ID: 20234306
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyethyl starch in sepsis.
Haase NR
Dan Med J; 2014 Jan; 61(1):B4764. PubMed ID: 24393593
[TBL] [Abstract][Full Text] [Related]
7. Rapid exacerbation of renal function after administration of hydroxyethyl starch in a dog.
Bae J; Soliman M; Kim H; Kang S; Kim W; Ahn S; Cho K; Choi J; Kim S; Park J; Kim S; DO Y; Yoo J; Yu D
J Vet Med Sci; 2017 Sep; 79(9):1591-1595. PubMed ID: 28867687
[TBL] [Abstract][Full Text] [Related]
8. Osmotic virial coefficients of hydroxyethyl starch from aqueous hydroxyethyl starch-sodium chloride vapor pressure osmometry.
Cheng J; Gier M; Ross-Rodriguez LU; Prasad V; Elliott JA; Sputtek A
J Phys Chem B; 2013 Sep; 117(35):10231-40. PubMed ID: 23862979
[TBL] [Abstract][Full Text] [Related]
9. Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial.
Godet G; Lehot JJ; Janvier G; Steib A; De Castro V; Coriat P
Eur J Anaesthesiol; 2008 Dec; 25(12):986-94. PubMed ID: 18492315
[TBL] [Abstract][Full Text] [Related]
10. [Effect of hydroxyethyl starch on acute renal injury in a model of hepatic ischemia-reperfusion].
Oliveira-Santos M; Lopes MF; Catré D; Gonçalves E; Cabrita A
Acta Med Port; 2012; 25(5):308-16. PubMed ID: 23211202
[TBL] [Abstract][Full Text] [Related]
11. Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis.
Müller RB; Haase N; Lange T; Wetterslev J; Perner A
Acta Anaesthesiol Scand; 2015 Mar; 59(3):329-36. PubMed ID: 25524831
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Hydroxyethyl Starch (6% HES 130/0.4) Kidney Storage in Critically Ill Dogs: A Post-mortem Prospective Study.
Adamik KN; Stoffel MH; Tangermann S; de Breuyn Dietler B; Stokar-Regenscheit N
Front Vet Sci; 2021; 8():802507. PubMed ID: 35071392
[No Abstract] [Full Text] [Related]
13. Impact of 6% hydroxyethyl starch 130/0.42 and 4% gelatin on renal function in a pediatric animal model.
Witt L; Glage S; Schulz K; Lichtinghagen R; Simann A; Pape L; Sümpelmann R
Paediatr Anaesth; 2014 Sep; 24(9):974-9. PubMed ID: 24916275
[TBL] [Abstract][Full Text] [Related]
14. Resuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injury.
Boussekey N; Darmon R; Langlois J; Alfandari S; Devos P; Meybeck A; Chiche A; Georges H; Leroy O
Crit Care; 2010; 14(2):R40. PubMed ID: 20298543
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyethyl starch-induced renal insufficiency after plasma exchange in a patient with polymyositis and liver cirrhosis.
Peron S; Mouthon L; Guettier C; Brechignac S; Cohen P; Guillevin L
Clin Nephrol; 2001 May; 55(5):408-11. PubMed ID: 11393388
[TBL] [Abstract][Full Text] [Related]
16. Infusion of 7.2% NaCl/6% hydroxyethyl starch 200/0.5 in on-pump coronary artery bypass surgery patients: a randomized, single-blind pilot study.
Lomivorotov VV; Fominskiy EV; Efremov SM; Nepomniashchikh VA; Lomivorotov VN; Chernyavskiy AM; Shilova AN; Karaskov AM
Shock; 2014 Mar; 41(3):193-9. PubMed ID: 24549094
[TBL] [Abstract][Full Text] [Related]
17. [Volume replacement solutions--pharmacology and clinical use].
Adams HA; Piepenbrock S; Hempelmann G
Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Jan; 33(1):2-17. PubMed ID: 9530478
[TBL] [Abstract][Full Text] [Related]
18. Osmotic nephrosis in a renal transplant recipient.
Ebcioglu Z; Cohen DJ; Crew RJ; Hardy MA; Ratner LE; D'Agati VD; Markowitz GS
Kidney Int; 2006 Nov; 70(10):1873-6. PubMed ID: 16883320
[No Abstract] [Full Text] [Related]
19. Hydroxyethylstarch as a risk factor for acute renal failure: is a change of clinical practice indicated?
Boldt J
Drug Saf; 2002; 25(12):837-46. PubMed ID: 12241125
[TBL] [Abstract][Full Text] [Related]
20. PRO: hydroxyethylstarch can be safely used in the intensive care patient--the renal debate.
Boldt J
Intensive Care Med; 2009 Aug; 35(8):1331-6. PubMed ID: 19533094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
